Line 66: | Line 66: | ||
<ul> | <ul> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Model">Overview</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Model">Overview</a></li> | ||
− | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration">Optimum Aptamer | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> |
Revision as of 09:31, 18 October 2021
![](https://static.igem.org/mediawiki/2021/b/ba/T--GreatBay_SCIE--Description_Header.png)
Team